BeiGene Ltd.

NASDAQ: BGNE · Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 9:00 PM

BeiGene Statistics

Share Statistics

BeiGene has 109.41M shares outstanding. The number of shares has increased by -0.79% in one year.

Shares Outstanding 109.41M
Shares Change (YoY) -0.79%
Shares Change (QoQ) -1.26%
Owned by Institutions (%) 43.88%
Shares Floating n/a
Failed to Deliver (FTD) Shares 986
FTD / Avg. Volume 0.28%

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Valuation Ratios

The PE ratio is -21.31 and the forward PE ratio is null. BeiGene's PEG ratio is 0.38.

PE Ratio -21.31
Forward PE n/a
PS Ratio 7.64
Forward PS n/a
PB Ratio 5.31
P/FCF Ratio -10.71
PEG Ratio 0.38
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BeiGene.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.26.

Current Ratio 2.32
Quick Ratio 2.09
Debt / Equity 0.26
Debt / EBITDA -0.83
Debt / FCF -0.53
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $231,960.28
Profits Per Employee $-83,180
Employee Count 10,600
Asset Turnover 0.42
Inventory Turnover 0.91

Taxes

Income Tax 55.87M
Effective Tax Rate -6.77%

Stock Price Statistics

The stock price has increased by 28.16% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been higher than the market average.

Beta 0.63
52-Week Price Change 28.16%
50-Day Moving Average 194.34
200-Day Moving Average 182.89
Relative Strength Index (RSI) 77.12
Average Volume (20 Days) 357,765

Income Statement

In the last 12 months, BeiGene had revenue of 2.46B and earned -881.71M in profits. Earnings per share was -0.65.

Revenue 2.46B
Gross Profit 2.08B
Operating Income -1.21B
Net Income -881.71M
EBITDA -1.12B
EBIT -1.21B
Earnings Per Share (EPS) -0.65
Full Income Statement

Balance Sheet

The company has 3.17B in cash and 930.18M in debt, giving a net cash position of 2.24B.

Cash & Cash Equivalents 3.17B
Total Debt 930.18M
Net Cash 2.24B
Retained Earnings -7.96B
Total Assets 5.83B
Working Capital 1.89B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.16B and capital expenditures -596.26M, giving a free cash flow of -1.75B.

Operating Cash Flow -1.16B
Capital Expenditures -596.26M
Free Cash Flow -1.75B
FCF Per Share -1.29
Full Cash Flow Statement

Margins

Gross margin is 84.55%, with operating and profit margins of -49.12% and -35.86%.

Gross Margin 84.55%
Operating Margin -49.12%
Pretax Margin -33.59%
Profit Margin -35.86%
EBITDA Margin -45.55%
EBIT Margin -49.12%
FCF Margin -71.32%

Dividends & Yields

BGNE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for BGNE is $288, which is 55.9% higher than the current price. The consensus rating is "Strong Buy".

Price Target $288
Price Target Difference 55.9%
Analyst Consensus Strong Buy
Analyst Count 6
Stock Forecasts

Scores

Altman Z-Score 3.5
Piotroski F-Score 4